Immediate Impact
1 by Nobel laureates 56 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Liting Liang being referenced
A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Liting Liang | 20 | 9 | 20 | 18 | 6 | 53 | |
| Ahmad Hosseinzadeh Adli | 17 | 4 | 38 | 16 | 7 | 73 | |
| George Ssebyatika | 25 | 13 | 18 | 30 | 8 | 78 | |
| Michael Graupe | 13 | 2 | 27 | 14 | 4 | 62 | |
| Lucy Rivett | 16 | 12 | 14 | 8 | 6 | 64 | |
| Iván del Moral-Sánchez | 18 | 15 | 23 | 5 | 59 | ||
| Niraja Suresh | 22 | 9 | 33 | 36 | 11 | 170 | |
| Gigliola Zanghì | 30 | 15 | 31 | 59 | 8 | 191 | |
| M Delforge | 18 | 10 | 21 | 3 | 7 | 45 | |
| Carina C. D. Joe | 22 | 5 | 20 | 22 | 7 | 54 | |
| Lance Presser | 14 | 5 | 32 | 24 | 8 | 83 |
All Works
Loading papers...